Moderna Inc (MRNA) — Cash Flow Quality Index
Latest as of September 2024:
-120.46x
Moderna Inc (MRNA) has a Cash Flow Quality Index of -120.46x as of September 2024. Operating cash flow of $-1.57 Billion is below net income of $13.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Moderna Inc (MRNA) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-120.46x
Operating CF / Net Income
Operating Cash Flow
$-1.57 Billion
USD
Net Income
$13.00 Million
USD
Data as of
Sep 2024
Most recent filing
Moderna Inc Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for Moderna Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see MRNA cash generation efficiency.
Annual Cash Flow Quality Index for Moderna Inc (2021–2022)
Year-by-year earnings quality comparison for Moderna Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.60x | $4.98 Billion | $8.36 Billion | ▼ -46.6% |
| 2021 | 1.12x | $13.62 Billion | $12.20 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.